Search research articles
Contact Us
Filters
Showing results (161-170 of 197) with videos related to
Page
of 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2006
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2015
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687
Evan Y Yu, Fenghai Duan, Mark Muzi, et al.
Cancer Discovery
|
December 10, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy
Amulya Sreekumar, Eric Blankemeyer, Christopher J Sterner, et al.
Molecular Imaging and Biology
|
May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer
Poorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2020
<sup>18</sup>F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer
Lanell M Peterson, Brenda F Kurland, Fengting Yan, et al.
Breast Cancer Research : BCR
|
August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
Perrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer
Hannah M Linden, Brenda F Kurland, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2015
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
Lale Kostakoglu, Fenghai Duan, Michael O Idowu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R Gerstner, Zheng Zhang, James R Fink, et al.
Molecular Imaging and Biology
|
November 22, 2025
First-in-Human Biodistribution and Dosimetry of [<sup>11</sup>C]Trimethoprim
Anthony J Young, Robert K Doot, Joshua K Cho, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 197) with videos related to
Sort By:
Page
of 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2006
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2015
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687
Evan Y Yu, Fenghai Duan, Mark Muzi, et al.
Cancer Discovery
|
December 10, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy
Amulya Sreekumar, Eric Blankemeyer, Christopher J Sterner, et al.
Molecular Imaging and Biology
|
May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer
Poorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2020
<sup>18</sup>F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer
Lanell M Peterson, Brenda F Kurland, Fengting Yan, et al.
Breast Cancer Research : BCR
|
August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
Perrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer
Hannah M Linden, Brenda F Kurland, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2015
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
Lale Kostakoglu, Fenghai Duan, Michael O Idowu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R Gerstner, Zheng Zhang, James R Fink, et al.
Molecular Imaging and Biology
|
November 22, 2025
First-in-Human Biodistribution and Dosimetry of [<sup>11</sup>C]Trimethoprim
Anthony J Young, Robert K Doot, Joshua K Cho, et al.
Page
of 20